Literature DB >> 24145092

1,2-Diazole prevents cisplatin-induced nephrotoxicity in experimental rats.

Venugopal Vinod Prabhu1, Narayanan Kannan, Chandrasekharan Guruvayoorappan.   

Abstract

BACKGROUND: Cisplatin (a platinum-compound) is a anti-neoplastic drug used in the treatment of various cancers but eventually results in severe adverse effects namely nephrotoxicity or renal disorder through generation of reactive oxygen species (ROS). This biochemical measurements and histopathology analysis investigated a possible protective effect of 1,2-diazole with regards to cisplatin-induced nephrotoxicity in experimental animals.
METHODS: Animals were divided into four groups of six mice each. Group A: normal control, vehicle (1% (w/v) gum acacia in phosphate buffer saline (PBS)). Group B: cisplatin group, vehicle + cisplatin (7.5 mg/kg). Group C: 1,2-diazole (10 mg/kg) + cisplatin and Group D: silymarin (50 mg/kg) + cisplatin. Each vehicle/drug treatment was given daily via intraperitoneal (ip) injection for 10 consecutive days starting from day 1. On group B, C and D cisplatin was given in single dose only on day 5 one hour post drug administration. Animals were allowed till 10th day and on day 11 all four groups animals were anesthetized. Blood samples were collected and serum was isolated for biochemical measurements. The rats were then euthanized by cervical dislocation and their kidney was recovered and then prepared for biochemical measurements and histopathology analyses.
RESULTS: Pretreatment with 1,2-diazole prevented nephrotoxicity induced by cisplatin through a protective mechanism that involved reduction of increased oxidative stress by significantly increasing the enzymatic and non enzymatic antioxidant enzymes such as glutathione peroxidase (GPx), glutathione (GSH) and diminishing the lipid peroxidation (LPO). The pretreatment with 1,2-diazole does not affect superoxide dismutase (SOD), catalase (CAT), serum urea and creatinine level during nephrotoxicity when compared to cisplatin-induced group. Moreover, the 1,2-diazole animals shown significant decrease in urine volume and kidney weight when compared with cisplatin-induced group. Histopathological findings reveals the protective efficacy of 1,2-diazole that restores histopathological changes against nephrotoxicity.
CONCLUSION: These analysis will provide a critical evidence that 1,2-diazole could provide a new protective strategy against cisplatin-induced nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24145092     DOI: 10.1016/s1734-1140(13)71079-x

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  9 in total

1.  Prevention of renal dysfunction by nutraceuticals prepared from oil rich plant foods.

Authors:  Sahar Y Al-Okbi; Doha A Mohamed; Thanaa E Hamed; Reham Sh Esmail; Souria M Donya
Journal:  Asian Pac J Trop Biomed       Date:  2014-08

2.  Protective effects of amifostine, curcumin, and melatonin against cisplatin-induced acute kidney injury.

Authors:  Filiz Mercantepe; Tolga Mercantepe; Atilla Topcu; Adnan Yılmaz; Levent Tumkaya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-02       Impact factor: 3.000

3.  Origanum majorana Attenuates Nephrotoxicity of Cisplatin Anticancer Drug through Ameliorating Oxidative Stress.

Authors:  Amel M Soliman; Shreen Desouky; Mohamed Marzouk; Amany A Sayed
Journal:  Nutrients       Date:  2016-05-05       Impact factor: 5.717

Review 4.  Styrylpyrazoles: Properties, Synthesis and Transformations.

Authors:  Pedro M O Gomes; Pedro M S Ouro; Artur M S Silva; Vera L M Silva
Journal:  Molecules       Date:  2020-12-12       Impact factor: 4.411

5.  Harmine mitigates cisplatin-induced renal injury in male mice through antioxidant, anti-inflammatory, and anti-apoptosis effects.

Authors:  Ali Ghanbari; Cyrus Jalili; Mohammad Reza Salahshoor; Setareh Javanmardy; Saeed Ravankhah; Nasim Akhshi
Journal:  Res Pharm Sci       Date:  2022-07-14

6.  Preparation and pharmacokinetics in beagle dogs of ganershu sustained-release pellets.

Authors:  Jin-Huo Pan; Jian-Chun Wang; Zhi-Tao Jiang; Ting Zhang; Shao-Bo Ge; Ye-Xia Zhang; Xin Jin; Guo-Jun Yan
Journal:  Pharmacogn Mag       Date:  2014-07       Impact factor: 1.085

7.  Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-Lipoxygenase inhibitors.

Authors:  Sahar A Ali; Samir Mohamed Awad; Ahmed Mohammed Said; Shahenda Mahgoub; Heba Taha; Naglaa Mohamed Ahmed
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

Review 8.  Natural and Biomimetic Antitumor Pyrazoles, A Perspective.

Authors:  Nádia E Santos; Ana R F Carreira; Vera L M Silva; Susana Santos Braga
Journal:  Molecules       Date:  2020-03-17       Impact factor: 4.411

Review 9.  Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET).

Authors:  Pedro M O Gomes; Artur M S Silva; Vera L M Silva
Journal:  Molecules       Date:  2020-04-09       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.